‘The link with nutrition and cancer risk and survival.’ 

Professor Helen Coleman is one of the leading research scientists in QUB. Professor Coleman’s research mostly focusses on the epidemiology and early detection of gastrointestinal cancer. She has a particular interest in Barrett’s Oesophagus and oesophageal cancer. 

Professor Helen Coleman gave a presentation at our recent festive zoom meeting. 

Nutrition and Cancer survival

• What’s in a name? Nutritionists & Dietitians
• Challenges for nutrition and cancer research
• Evidence and guidelines for nutrition and cancer:
(i) Risk
(ii) During treatment
(iii) Survival after treatment

View Presentation

Early Diagnosis is Key #CatchItEarly

Oesophageal cancer like many other cancers does not discriminate between age or sex and knowing and recognising the signs and symptoms are crucial to early diagnosis.  If you suffer from any of the following symptoms for longer than 3 weeks you should consult your doctor.

  • Persistent Indigestion
  • Difficulty swallowing or food sticking
  • Heartburn acid reflux
  • Hiccupping that wont go away
  • Unexplained weight loss.

Latest News

Access all of our latest news, press releases, and newsletters in one place! Stay informed of new treatments, research and events.

News

Paul Marshall releases ‘BodyShots’ – a visual art exhibition detailing his stomach cancer journey

    Bodyshots are blows received to the torso during combat that weaken the opponent. Bodyshots is an art exhibition about Stomach Cancer and how resilience, community and love were...

Continue Reading
News

Northern Ireland Cancer Registry release latest stats on stomach and oesophageal cancers

The Northern Ireland Cancer Registry have released the latest official stats in relation to stomach and oesophageal cancers, covering the period from 1993 – 2022. Both reports can be found...

Continue Reading
News

Chairperson’s comment on spiralling waiting times for OG patients

OGCancerNI findings highlight a critical issue with significant implications for patients’ survival and well-being. Long waiting times, especially for those with red flag referrals for suspected cancer, not only delay life-saving...

Continue Reading